Improving Patient Safety by Supporting Older Adults in Managing Sleep Problems.
NCT06584513 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 470
Last updated 2025-09-30
Summary
Among older adults (≥65 years), use of sleeping pills, such as benzodiazepines and other sedative-hypnotics, to treat sleep problems is common. While sleeping pills are effective in the first few weeks of use, their effect diminishes significantly after that. Especially older adults are susceptible to significant adverse effects of sleep pills, yet stopping sleeping pills remains challenging. BE-SAFE aims to conduct a randomised study testing a patient-centred intervention to reduce sleeping pill use and to improve patient safety and quality of care focusing on implementation aspects. The intervention addresses knowledge and practice gaps related to discontinuation of sleeping pills in older adults with sleep problems.
Conditions
- Benzodiazepines Deprescribing
- Sleep Problems
Interventions
- OTHER
-
Specific tapering plan for sleep medication, educational and cognitive behavioural therapy elements
The intervention consists of a patient-centred intervention to help patients in deprescribing BSHs and better managing their sleep problems. The material used consists of training modules, brochures, and self-monitoring tools. There are materials for physicians and for patients.
Sponsors & Collaborators
-
Universitat Autonoma de Barcelona
collaborator OTHER -
Oslo University Hospital
collaborator OTHER -
National and Kapodistrian University of Athens
collaborator OTHER -
Institute of Psychiatry and Neurology, Warsaw
collaborator OTHER -
CHU UCL Namur
collaborator UNKNOWN -
Université Catholique de Louvain
collaborator OTHER -
Insel Gruppe AG, University Hospital Bern
lead OTHER
Principal Investigators
-
Nicolas Rodondi, MD, MAS · University Hospital Bern (Inselspital)
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-11-18
- Primary Completion
- 2026-02-01
- Completion
- 2026-02-01
Countries
- Belgium
- Greece
- Norway
- Poland
- Spain
- Switzerland
Study Locations
More Related Trials
-
Telepsychology for Benzodiazepines Withdrawal in Adults Suffering From Hypnotic-dependent Insomnia
NCT04751851 ·Status: COMPLETED ·Phase: NA
-
Self Help Program for Hypnotics Withdrawal in Insomniac Patients
NCT02720458 ·Status: COMPLETED ·Phase: NA
-
Brief Intervention for Sleep Medication Misuse Among Elderly
NCT06032715 ·Status: RECRUITING ·Phase: NA
-
Insomnia Behavioral Intervention Study
NCT05301543 ·Status: RECRUITING ·Phase: NA
-
Use of Blinded Tapering for Hypnotic Discontinuation
NCT04050176 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Study to Determine Whether Ramelteon Helps People With REM Sleep Behavior Disorder
NCT01401413 ·Status: COMPLETED ·Phase: PHASE4
-
Sleep Without Insomnia or The Use of Chronic Hypnotics
NCT03687086 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Tolerability of Ramelteon in Patients With Rapid Eye Movement (REM) Behavior Disorder and Parkinsonism
NCT00745030 ·Status: TERMINATED ·Phase: NA
-
Efficacy and Safety of Melatonin and Clonazepam for IRBD
NCT03255642 ·Status: COMPLETED ·Phase: NA
-
Safety of Ramelteon in Elderly Subjects
NCT00568789 ·Status: COMPLETED ·Phase: PHASE4
-
Risk and Benefit Assessment of Hypnotic Agents for Sleep Disorders Among Elderly
NCT02648776 ·Status: UNKNOWN
-
Combined Behavioral/Pharmacological Therapy for Insomnia
NCT00044629 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of ACT-541468 in Elderly Subjects With Insomnia Disorder
NCT02841709 ·Status: COMPLETED ·Phase: PHASE2
-
Behavioral and Pharmacological Treatment for Insomnia
NCT00042146 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy of Ramelteon in Elderly Subjects With Chronic Insomnia.
NCT00671294 ·Status: COMPLETED ·Phase: PHASE3
-
Imaging the Effects of Zolpidem and Alprazolam in Healthy Volunteers at 3T
NCT01747590 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia
NCT00606593 ·Status: COMPLETED ·Phase: PHASE2
-
Non-pharmacological Treatment of Insomnia in Nursing Homes.
NCT01091987 ·Status: COMPLETED ·Phase: NA
-
ZOlpidem and the stRengthening of pRescription regulatiOn
NCT03584542 ·Status: COMPLETED
-
Safety and Efficacy of Ramelteon in Adults With Chronic Insomnia
NCT00237497 ·Status: COMPLETED ·Phase: PHASE3
-
The Effects of Tasimelteon in Participants With REM Behavior Disorder (RBD)
NCT05922995 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Ramelteon vs Placebo for Prevention of Delirium and Improvement of Sleep in Hospitalized Older Adults
NCT03165695 ·Status: WITHDRAWN ·Phase: PHASE4
-
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Bayesian Adaptive Randomization Design, Dose Response Study of the Efficacy of E2006 in Adults and Elderly Subjects With Chronic Insomnia
NCT01995838 ·Status: COMPLETED ·Phase: PHASE2
-
The Study of Combination Use of Melatonin Receptor Agonist for Dose Reduction or Interruptions of Benzodiazepine (BZD) and Non-BZD Hypnotics on Chronic Insomnia
NCT03461042 ·Status: COMPLETED ·Phase: PHASE4
-
SM-1 vs 2 Comparators and Placebo in Participants With a History of Transient Insomnia.
NCT03331042 ·Status: COMPLETED ·Phase: PHASE3